The Ministry of Health of Paraguay has approved the Russian Sputnik V vaccine against coronavirus, the Russian Direct Investment Fund (RDIF) said.
The vaccine was registered under the emergency use authorization procedure without additional clinical trials in the country. Sputnik V had been registered under the same procedure earlier in Algeria, Argentina, Bolivia, Serbia, Palestine, and Venezuela.
Supplies of the vaccine will be facilitated by RDIF’s international partners in India, China, South Korea, and other countries.
Registration of the Sputnik V vaccine in Paraguay proves the increasing interest of Latin American countries in a safe and effective Russian vaccine against coronavirus. We expect that more countries in the region will also approve it soon and are ready to create new partnerships to pool efforts in the fight against the pandemic, Kirill Dmitriev, CEO of the RDIF, said.
The RDIF earlier announced that the Ministry of Health of Venezuela registered the Russian Sputnik V vaccine against coronavirus.